Study Protocol
A protocol for international consensus guideline development on the delineation of radiotherapy target volumes for nasopharyngeal carcinoma after induction chemotherapy
Annals of Nasopharynx Cancer
2023;
7:
1
(30 November 2023)
Review Article
Classifying the tumor microenvironment to stratify nasopharyngeal carcinoma patients
Annals of Nasopharynx Cancer
2022;
6:
8
(30 September 2022)
Review Article
Clinical utility of circulating tumor cells for real-time serial monitoring of nasopharyngeal carcinoma patients
Annals of Nasopharynx Cancer
2022;
6:
7
(30 June 2022)
Review Article
Utility of Epstein-Barr virus (EBV) antibodies as screening markers for nasopharyngeal carcinoma: a narrative review
Annals of Nasopharynx Cancer
2022;
6:
6
(30 June 2022)
Review Article
CpG methylation as epigenetic biomarkers for nasopharyngeal carcinoma diagnostics
Annals of Nasopharynx Cancer
2022;
6:
5
(30 June 2022)
Review Article
Plasma Epstein-Barr virus DNA analysis for personalised management of nasopharyngeal carcinoma—current opportunities and challenges
Annals of Nasopharynx Cancer
2022;
6:
4
(30 March 2022)
Review Article
Epstein-Barr virus-based nasopharyngeal carcinoma population screening
Annals of Nasopharynx Cancer
2022;
6:
3
(30 March 2022)
Review Article
Prognostic value of Epstein-Barr virus biomarkers for nasopharyngeal carcinoma staging and post-treatment surveillance
Annals of Nasopharynx Cancer
2022;
6:
2
(30 March 2022)
Editorial
The etiology of nasopharyngeal carcinoma and challenges for its diagnosis and treatment monitoring
Annals of Nasopharynx Cancer
2022;
6:
1
(30 March 2022)
Review Article
Stereotactic radiation therapy for recurrent nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2021;
5:
5
(30 June 2021)
Editorial
EBV and NPC carcinogenesis—an alternative viewpoint
Annals of Nasopharynx Cancer
2021;
5:
4
(30 June 2021)
Review Article
miRNA biomarkers for NPC diagnosis and prognosis
Annals of Nasopharynx Cancer
2021;
5:
3
(30 June 2021)
Review Article
Biological opportunities for personalized radiotherapy of nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2021;
5:
2
(14 May 2021)
Editorial
Precision radiotherapy in nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2021;
5:
1
(14 May 2021)
Case Report
Ectopic parathyroid adenoma in pyriform sinus: a case report and literature review
Annals of Nasopharynx Cancer
2020;
4:
15
(30 December 2020)
Editorial
Introduction: late complications in the management of nasopharyngeal cancer
Annals of Nasopharynx Cancer
2020;
4:
14
(30 December 2020)
Review Article
Managing hidden late complications in irradiated head and neck cancer patients using a practical integrative approach: a narrative review
Annals of Nasopharynx Cancer
2020;
4:
13
(06 November 2020)
Review Article
Treatment of nasopharyngeal carcinoma in unique scenarios
Annals of Nasopharynx Cancer
2020;
4:
12
(06 November 2020)
Original Article
Local radiotherapy combined with systemic therapy for metastatic nasopharyngeal carcinomas at diagnosis: experience from a tertiary academic center in the Philippines
Annals of Nasopharynx Cancer
2020;
4:
11
(06 November 2020)
Review Article
Narrative review: temporal lobe necrosis after radiotherapy for nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2020;
4:
10
(19 October 2020)
Review Article
Ototoxicity after chemoradiotherapy for nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2020;
4:
9
(19 September 2020)
Original Article
Quality of life outcome among nasopharyngeal carcinoma survivors in Kuala Lumpur
Annals of Nasopharynx Cancer
2020;
4:
8
(10 September 2020)
Review Article
Salivary glands and dental complications after radiotherapy for nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2020;
4:
7
(31 August 2020)
Review Article
Knowledge-based planning in nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2020;
4:
6
(19 August 2020)
Review Article
Combination of precision radiotherapy with chemotherapy and immunotherapy in non-recurrent/metastatic nasopharyngeal carcinoma
Annals of Nasopharynx Cancer
2020;
4:
5
(21 July 2020)